Abstract

Research Article

Geopolitical issues in health and biosecurity concerning gain-of-function research, emergence and re-emergence of infectious diseases

Chrysanthus Chukwuma Sr*

Published: 04 March, 2022 | Volume 6 - Issue 1 | Pages: 011-016

There are global concerns in the dissemination and transmission dynamics of emerging and reemerging infectious diseases and the underlying features of gain-of-function research and geopolitics within and across borders. These concerns have become pertinent in the management of local and global health because the disease is perspicuously a geopolitical issue ostensibly linked to gain-of-function research where health diplomacy focuses on the present and future global emergence and re-emergence of infectious diseases, pandemics, and microbiome variants. These have generated vehement reactions with a propensity for extreme geopolitics and gain-of-function natural and anthropogenic activities. Geopolitical parameters and gain-of-function issues impact the social determinants of health and vice versa. The convening and convergence of countries for unprecedented epidemic or pandemic treaty settings or other formulations to confront emerging and reemerging infectious diseases will afford considerable opportunities concerning challenges in action, preparedness, and response. Provisions are pertinent for legal instruments, effective and efficient systems to curb future threats and outbreaks of infectious diseases. 

Read Full Article HTML DOI: 10.29328/journal.ijcv.1001043 Cite this Article Read Full Article PDF

Keywords:

Vaccines; Treatment; AIDS; HIV; SARS-CoV-2; Vulnerable populations

References

  1. Chukwuma Sr C. Syndemics of chronic and acute diseases in vulnerable populations. 2021.
  2. Chukwuma Sr C. Perspectives in the emergence and reemergence of infectious diseases, geopolitics and gain-of-function research. Scholars Int J Biochem.
  3. Chukwuma Sr C. Ecosystem cadastre of plant-soil interactions with nonferrous metals. IJCRCPS. 8: 17-26.
  4. Baker RE, Mahmud AS, Miller IF, Rajeev M, Rasambainarivo F, Rice BL et al. Infectious disease in era of global change. Nat Rev Microbiol. 2021; 1-13.PubMed: https://pubmed.ncbi.nlm.nih.gov/34646006/
  5. Evans TS, Shi Z, Boots M, Liu W, Olival KJ, Xiao X et al. Synergistic China-US ecological research is essential for global emerging infectious disease preparedness. Ecohealth. 2020; 17: 160-173. PubMed: https://pubmed.ncbi.nlm.nih.gov/32016718/
  6. Chavan M, Qureshi H, Karnati S, Kollikonda S. COVID-19 vaccination in pregnancy: The benefits outweigh the risks. J Obstet Gynaecol Can, 2021; 43: 814-816. PubMed: https://pubmed.ncbi.nlm.nih.gov/34253304/
  7. Chukwuma Sr C. Challenges and opportunities in accessing veritable vaccines and curbing the dissemination and excesses of the SARS-CoV-2 or COVID-19 variants. Middle East Publishers Scholars. Int J Biochem. 4: 108-111.
  8. Sabin NS, Calliope AS, Simpson SV, Arima H, Ito H, et al. Implications of human activities for (re)emerging infectious diseases, including COVID-19. J Physiol Anthropol. 2020; 39: 29. PubMed: https://pubmed.ncbi.nlm.nih.gov/32977862/
  9. Chukwuma Sr C. Acquired immunodeficiency syndrome in sub-Saharan Africa: Epidemiological, sociological and preventive perspectives. Scandinavian J Develop Alternatives. 1996; 15: 74-89.
  10. Greenwood M. What is gain-of-function research? https://www.news-medical-net/health/What-is-Gain-of-Function-Research.aspx
  11. Cele S, Gazy I, Jackson L, et al. Escape of SARS-CoV-2 501Y.V2 variants from neutralization by convalescent plasma. Nature. 2021. https://www.nature.com/articles/s41586-021-03471-w.
  12. The Economist. Will the COVID-19 pandemic make this year's flu season worse? 2021.
  13. Chukwuma Sr C. Environmental health perspectives on the emergence and re-emergence of infectious diseases, geopolitics and gain-of-function research. J Biomed Res Environ Sci. 2021.
  14. Chukwuma Sr C. Information and communication needs in the administration of ibuprofen in the treatment of symptoms in COVID-19 patients. JMR. 2020; 6: 128-130.
  15. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020; 94; e00127-20.PubMed: https://pubmed.ncbi.nlm.nih.gov/31996437/
  16. Fang L, Karakiulakis, Roth M. Are patients with hypertension and diabetes at increased risk for COVID-19 infection? Lancet Respir Med. 2020; 8: e21. PubMed: https://pubmed.ncbi.nlm.nih.gov/32171062/
  17. Day M. COVID-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ. 2020; 368: m1086. PubMed: https://pubmed.ncbi.nlm.nih.gov/32184201/
  18. Excler JL, Seville M, Berkley S, Kim JH. Vaccine development for emerging infectious diseases. Nat Med. 2021; 27: 591-600. PubMed: https://pubmed.ncbi.nlm.nih.gov/33846611/
  19. Chukwuma Sr C. The impacts of mining operations in Nigeria with particular reference to the Enyigba-Abakaliki area. Int J Env Edu Inf. 12: 321-336.
  20. Chukwuma Sr C. Information-base and determinants of medical specialization and primary care: A view point. JBAH. 4.
  21. Chukwuma Sr C, Bjurulf P. A case study of the information-base needed for effective evaluation of primary health care programmesin Anambra State, Nigeria. Int J Health Sc. 1990; 1: 137-148.
  22. Chukwuma Sr C. Ecological analysis of the COVID-19 pandemic for restoration and sustainability. Res Advan Pharm Life Sci. 2021; 3.
  23. Chukwuma Sr C. Defining environmental management and planning policy in Nigeria. Int J Agric Med Rural Health. 1996; 20: 13-18.
  24. Sawanpanyalert P. Roles of multi-country networking in prevention and control of emerging and re-emerging infections. Trop Med & Health. 2006; 34: 149-152.
  25. Schwartz DA, Herman CJ. Editorial Response: The importance of the autopsy in emerging and reemerging infectious diseases. Clin Infect Dis. 1996; 23: 248-254. PubMed: https://pubmed.ncbi.nlm.nih.gov/8842258/
  26. Fidler DP. Germs, governance, and global public health in the wake of SARS. J. Clin. Invest. 2004; 113: 799-804. PubMed: https://pubmed.ncbi.nlm.nih.gov/15067309/
  27. Mykhalovskiy E, Weir L. The geopolitics of global public health surveillance in the twenty-first century. In: Bashford A(eds). Medicine at the Border. 2007. Palgrave MacMillan London.
  28. Chukwuma Sr C. Probing the emergence and the re-emergence of infectious diseases, geopolitics and gain-of-function research. 2021.
  29. Chukwuma Sr C. Pathophysiologic functions of carbohydrate-lipid interactions: Ascertainment in obesity, diabetes and SARS-CoV-2/COVID-19. J Biotechnol Its Applications. 2022; 1: 1-6.
  30. Chukwuma Sr C. Restoration and sustainability of petroleum-contaminated sites in the human environment. J Clin Trials Regulations. 2019; 1: 57-70.
  31. Dodds K, Cole J. Unhealthy geopolitics: Can the response to COVID-19 reform climate change policy? Bull. World Health Organ. 2021; 99: 148-154.
  32. Tabor E, Gerety RJ, Cairns J, Bayley AC. Did HIV and HTLV originate in Africa? (letter). JAMA. 1990; 264: 691-692.
  33. Ardoo A. The limits and prospects of AIDS legislation in anglophone Africa. Int-Conf-AIDS. 1990; 5: 941.
  34. Africa unlikely to end AIDS as public health threat by 2030. 2021.
  35. Chukwuma Sr C. Features in the emergence and reemergence of infectious diseases, gain-of-function and geopolitics. Boomed J Sci Tech Res. 2022; 4.
  36. Chukwuma Sr C. Cryptosporidium: public health problems and environmental indicators. Austin Med Sci. 2019; 4: 1036.
  37. Chukwuma Sr C. The Clinicopathological correlates of cystoisosporiasis in immunocompetent, immunocompromised and HIV-infected/AIDS patients but neglected in SARS-CoV-2/COVID-19 patients? Int J Clin Microbiol Biochem Technol. 2021; 4: 001-004. https://www.heighpubs.org/hcmbt/ijcmbt-aid1018.php
  38. Chukwuma Sr C. Microsporidium in AIDS patients - A perspective. East Afr Med J. 1996; 73: 72-75. PubMed: https://pubmed.ncbi.nlm.nih.gov/8625869/
  39. Sen M, Honavar SG, Sharma N, Sachdev MS. COVID-19 eye. A review of ophthalmic manifestations of COVID-19. Ind J Ophthalmol. 2021; 69: 488-509. PubMed: https://pubmed.ncbi.nlm.nih.gov/33595463/
  40. Chukwuma Sr C. Explicating the presentations of Acanthamoeba keratitis with special concern in the COVID-19 pandemic ambient. Int J Clin Microbiol Biochem Technol. 4: 010-015. https://www.heighpubs.org/hcmbt/ijcmbt-aid1020.php
  41. Jones L, Walsh K, Willcox M, Morgan P, Nichol J. The COVID-19 pandemic: important considerations for contact lens practitioners. Cont Lens Anterior Eye. 2020; 43: 196-203. PubMed: https://pubmed.ncbi.nlm.nih.gov/32273245/
  42. Chukwuma Sr C. Comments on the environmental health implications of Acanthamoeba. Int J Env Hlth Res. 1996; 6: 49-54.
  43. Chukwuma Sr C. Application of global concepts to the Nigerian food crisis. Economic Planning in Free Societies. J Agri Related Studies. 1995; 31: 3-9.
  44. National Academies Press (US). Gain-of-Function Research. Background and Alternatives. 2015. PubMed: https://www.ncbi.nim.nih.gov/books/NBK285579
  45. News Feature. The shifting sands of ''gain-of-function'' research. Nature. 2021..
  46. Cao C. China's evolving biosafety/biosecurity legislations. J Law Biosci. 2021; 8: PubMed: https://pubmed.ncbi.nlm.nih.gov/34221436/
  47. Selgelid MJ. Gain-of-Function Research: Ethical analysis. Sci Eng Ethics. 2016; 22: 923-964. PubMed: https://pubmed.ncbi.nlm.nih.gov/27502512/
  48. Chukwuma Sr C. Undergirding environmental legislation and citizen participation in developing countries. Int J Env Edu Inf. 1996; 15: 319-330.
  49. Chukwuma Sr C. Perspectives for a sustainable society. Environ Manage Health. 1996; 7: 6-20.
  50. Chenneville T, Gabbidon K, Hanson P, Holyfield C. The impact of COVID-19 on HIV treatment and research: A call to action. Int J Environ Res Public Health. 2020; 17: 45-48. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345635/
  51. Chukwuma Sr C. Accessing vaccines with compliance to stem the emergence and dissemination of the SARS-CoV-2 or COVID-19 variants. eBook. Research Trends of Microbiology. MedDocs Publishers LLC. 3: 12-15.
  52. Morens DM, Fauci AS. Emerging pandemic diseases: How we got to COVID-19. Cell. 2020; 182: 1077-1092. PubMed: https://pubmed.ncbi.nlm.nih.gov/32846157/

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More